The Ministry of Food and Drug Safety (MFDS) plans to strengthen the control of medical narcotics by making the most of the risk management plan (RMP).Drug Safety Planning Officer Chae Kyu-han said the ministry would shore up the management of medical narcotics through RMPs and provide more safety in
The Ministry of Health and Welfare's announcement on Tuesday to increase medical school admissions by 2,000 students from the 2025 academic year has sparked a major backlash from doctors.This marks the most significant expansion in medical education capacity in 27 years, elevating the current quota
Some users of spinal muscular atrophy (SMA) treatment Spinraza (nusinersen) failed to get reimbursement because their motor function was not maintained or improved after its administration.The Health Insurance Review and Assessment Service (HIRA) released the results of the recent Medical Review and
A bill has passed the National Assembly's plenary session, restricting medical residents from working more than 80 hours weekly.The new law will also prohibit doctor trainees from working more than 36 hours in a row and provide the basis for prioritizing the fostering of specialists in essential med
Enhertu (trastuzumab deruxtecan), a next-generation antibody-drug conjugate (ADC) developed by Daiichi Sankyo, recently passed the Pharmaceutical Reimbursement Evaluation Committee (PREC)'s deliberations, moving closer toward health insurance coverage.On Thursday, the Health Insurance Review and Ass
Astellas Korea's ADC (antibody-drug conjugate) drug Padcev Inj (enfortumab vedotin) has passed the Cancer Disease Review Committee (CDRC).On Wednesday, the Health Insurance Review and Assessment Service (HIRA) released the insurance benefit standard deliberation results at this year’s first CDRC mee
President Yoon Suk Yeol said non-face-to-face medical treatment should be viewed from the perspective of developing the bio-medical industry, emphasizing that the government would pursue policies to attain administrative goals by fostering related industries rather than regulating them.President Yoo
As prescriptions for growth hormone injections have sharply increased, so have the number of reports on adverse events associated with growth hormone injections.Against this backdrop, a physician-turned-lawmaker recently called for attention to the risk of growth hormone abuse and misuse.Rep. Shin H
An increasing number of Korean healthcare firms have been designated unfaithful disclosure companies or are at risk of receiving a similar notice.The Kosdaq Market Headquarters designates companies that fail to fulfill their disclosure obligations as mandated by related regulations as unfaithful dis
Digital healthcare has been called the "inevitable future." However, there are also voices in the field that say it's "doctors' self-satisfaction" or "serving corporate interests."Critics say that all parties involved have only paid attention to its possibilities while neglecting to evaluate it prop
The Ministry of Trade, Industry and Energy (MOTIE) revealed on Thursday its commitment to allocate a total budget of 266 billion won ($199 million) for bio research and development (R&D) this year.In 2024, the ministry's focus will be on advancing biopharmaceuticals, including innovative new drugs,
The Minister of Health and Welfare, Cho Kyoo-hong, highlighted the necessity of augmenting the medical school enrollment quota in Korea during the health ministers’ meeting of the Organization for Economic Cooperation and Development (OECD).The Ministry of Health and Welfare said Cho attended the OE
The Health Insurance Review and Assessment Service (HIRA) recently hit back against criticism about the delayed reimbursement process for new drugs, including Enhertu and Ilaris.HIRA issued a news release last Wednesday, rebutting some media reports that the government's lukewarm attitude is delayin
Samsung Biologics said Monday that it has been awarded the Platinum medal, the highest rating awarded to only the top 1 percent of companies worldwide, in the ESG assessment by global sustainability research organization EcoVadis.After achieving a Gold rating in 2022, Samsung Biologics moved up a no
Korea is currently facing a significant ethical and legal dilemma in its medical sector due to increasing instances of doctors performing surgeries while under the influence of alcohol.This issue gained national attention following an incident in January, where a young surgeon in Seoul conducted fac
The number of cases of norovirus infection has surged, reaching the highest level in five years.In addition, various respiratory infections, including respiratory syncytial virus (RSV), have broken out, prompting the health authorities to rush to activate the emergency quarantine system.The Korea Di
Following the subsiding of the Covid-19 pandemic and a return to normalcy, influenza cases in Korea witnessed a remarkable surge of over 9,000 percent from 2021 to 2022. Yet, over the past four years, there has been a consistent annual decrease in the number of flu cases, averaging 25 percent.The Na
As the Korea Disease Control and Prevention Agency (KDCA) considers expanding the HPV (human papillomavirus) national immunization program to 12-year-old boys while only covering the first dose, the medical community criticized it as a "half-measure."A single dose is not enough to provide protection
The Ministry of Food and Drug Safety has increased its budget by 2.34 billion won ($1.74 million) to help digital therapeutic devices (DTx) enter the market quickly.The increased budget breaks down into 230 million won for innovative medical device technology support, 1.46 billion won for clinical,
Korea's first "infectious disease hospital" will begin construction in the first half of this year.The Korea Disease Control and Prevention Agency (KDCA) said Thursday that it would build a hospital specializing in infectious diseases at Chosun University Hospital through public bidding. The bidding